| Date Filed | Type | Description |
| 06/16/2023 |
4
| Kung Winston (Director) has filed a Form 4 on Janux Therapeutics, Inc.|
Txns:
| Granted 12,500 options to buy
@ $13.22, valued at
$165.3k
|
|
| 05/15/2023 |
4
| Kung Winston (COO, CFO) has filed a Form 4 on PMV Pharmaceuticals, Inc.|
Txns:
| Granted 150,000 options to buy
@ $5.7, valued at
$855k
|
|
| 01/30/2023 |
4
| Kung Winston (COO, CFO) has filed a Form 4 on PMV Pharmaceuticals, Inc.|
Txns:
| Gifted 2,560 shares
@ $0 |
|
| 09/22/2022 |
4
| Kung Winston (Director) has filed a Form 4 on Janux Therapeutics, Inc.|
Txns:
| Granted 30,000 options to buy
@ $13.54, valued at
$406.2k
Granted 9,375 options to buy
@ $13.54, valued at
$126.9k
|
|
| 09/22/2022 |
3
| Kung Winston (Director) has filed a Form 3 on Janux Therapeutics, Inc. |
| 04/21/2022 |
4
| Kung Winston (COO, CFO) has filed a Form 4 on PMV Pharmaceuticals, Inc.|
Txns:
| Exercised 4,000 options to buy
@ $3.22, valued at
$12.9k
|
|
| 02/28/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/08/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/20/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/04/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/08/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/08/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/07/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/04/2021 |
4
| Kung Winston (COO, CFO) has filed a Form 4 on PMV Pharmaceuticals, Inc.|
Txns:
| Sold 4,500 shares
@ $33.75, valued at
$151.9k
Exercised 4,500 options to buy
@ $3.22, valued at
$14.5k
|
|
| 12/31/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 09/24/2020 |
3
| Kung Winston (COO, CFO) has filed a Form 3 on PMV Pharmaceuticals, Inc. |
| 02/29/2016 |
3
| Kung Winston (Director) has filed a Form 3 on Alliqua BioMedical, Inc. |